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Background: In 2006, the Canadian Cardiovascular Society (CCS) Access to Care Working Group recommended a
30-day wait time benchmark for cardiac rehabilitation (CR). The objectives of the current study were to: (1) describe
cardiac patient perceptions of actual and ideal CR wait times, (2) describe and compare cardiac specialist and CR
program perceptions of wait times, as well as whether the recommendations are appropriate and feasible, and (3)
investigate actual wait times and factors that CR programs perceive to affect these wait times.
Methods: Postal and online surveys to assess perceptions of CR wait times were administered to CR enrollees at
intake into 1 of 8 programs, all CCS member cardiac specialists treating patients indicated for CR, and all CR
programs listed in Canadian directories. Actual wait times were ascertained from the Canadian Cardiac
Rehabilitation Registry. The design was cross-sectional. Responses were described and compared.
Results: Responses were received from 163 CR enrollees, 71 cardiac specialists (9.3% response rate), and 92 CR
programs (61.7% response rate). Patients reported that their wait time from hospital discharge to CR initiation was
65.6 ± 88.4 days (median, 42 days), while their ideal median wait time was 28 days. Most patients (91.5%)
considered their wait to be acceptable, but ideal wait times varied significantly by the type of cardiac indication for
CR. There were significant differences between specialist and program perceptions of the appropriate number of
days to wait by most indications, with CR programs perceiving shorter waits as appropriate (p < 0.05). CR programs
reported that feasible wait times were significantly longer than what was appropriate for all indications (p < 0.05).
They perceived that patient travel and staff capacity were the main factors negatively affecting waits. The median
wait time from referral to program initiation was 64 days (mean, 80.0 ± 62.8 days), with no difference in wait by
indication.
Conclusions: Wait times following access to cardiac rehabilitation are prolonged compared with consensus
recommendations, and yet are generally acceptable to most patients. Wait times following percutaneous coronary
intervention in particular may need to be shortened. Future research is required to provide an evidence base for
wait time benchmarks.Background
Timely access to cardiac care is important to ensure the
best patient outcomes [1]. This holds true not only for
acute cardiac care [2], but also applies to outpatient car-
diac care [3,4]. Indeed, there is a high risk of subsequent
or recurrent events in the period after an acute cardiac* Correspondence: sgrace@yorku.ca
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reproduction in any medium, provided the orhospitalization [5], and this is often a time of acute distress
for patients and their families. To optimize patients’ post-
discharge health and well-being, timely access to second-
ary prevention is required [6]. Cardiac rehabilitation (CR)
is an outpatient chronic disease management program
designed to improve and maintain cardiovascular health
through individualized, inter-professional care. CR pro-
grams offer medical assessment, structured exercise, and
client and family education, as well as comprehensive risk
factor and behavior modification. It is an effective meanstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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evidenced by the 25% reduction in morbidity and mortal-
ity compared with usual care [7]. Based on this evidence,
CR is recommended as the standard of care in clinical
practice guidelines for acute coronary syndrome and
revascularization [8,9], among other cardiac populations
[8,10,11].
In 2004, the Canadian Cardiovascular Society (CCS)
formed an Access to Care Working Group to establish
reasonable, safe wait times for access to cardiovascular
services and procedures [1]. Wait time benchmarks for
CR services were established by cardiac indication based
on clinical consensus [12]. The benchmarks specified
the upper limit of both preferable and acceptable wait
times, which provided a reasonable standard for physi-
cians to treat patients based on the level of predicted
risk. The overall recommendation was for a 30 calendar
day “preferable” wait time from referral to start of the
exercise program in CR, with 60 days as “acceptable”. In
2010, the Canadian Medical Association Wait Time Alli-
ance published wait time benchmarks for cardiac sur-
gery, as well as for access to cardiac services throughout
the continuum, including cardiac rehabilitation (http://
www.waittimealliance.ca/waittimes/cardiac_care.htm).
Little is known whether the care provided meets these
recommended benchmarks, or whether key stakeholders
perceive the wait times as acceptable, appropriate and
feasible. In 2001, CR participants from 24 sites (45% of
Ontario’s programs) were investigated, and the results
showed that the mean and median times from cardiac
event to CR referral were 71 and 31 days, respectively
(range, 1 day to 2 years), and from the patient referral to
intake to the CR program, the times were 111 and
72 days, respectively [13]. In 2003, a technology report
concluded that most Canadian CR programs are running
at or near capacity, and have waiting lists for admission
from weeks to months [14]. Therefore, the objectives of
the current study were to: (1) describe cardiac patient
perceptions of actual and ideal CR wait times by cardiac
indication for CR and whether they consider their wait
acceptable; and (2) describe and compare cardiac spe-
cialist and CR program perceptions of the proportion of
patients receiving CR within CCS-recommended wait
times, as well as whether the recommendations are ap-
propriate and feasible. Finally, with regard to CR pro-
gram perceptions, the third objective was to: (a) describe
program-reported CR wait times, (b) describe program
awareness of wait time benchmarks, and (c) investigate
factors that CR programs perceive to affect wait times.
Methods
We present data from 3 cross-sectional studies and the
Canadian Cardiac Rehabilitation Registry (www. cacr.ca/
resources/registry.cfm). These studies were approved bycorresponding institutional research ethics boards, as
well as York University’s Office of Research Ethics. For
the first study, 163 consenting CR enrollees from 1 of 8
urban and regional CR programs in Ontario participated.
New patients were approached consecutively by study
staff and were provided a self-report survey at program
intake. Wait time items were incorporated into a survey
of a larger study on inter-provider communication
(detailed methods shown elsewhere; [15]).
For the second study, a survey was mailed to all 44
Ontario CR programs in early 2010. Each CR program
received a personalized cover letter, questionnaire, and
pre-paid return envelope. A similar anonymous online
survey was sent to all 105 CR programs outside of On-
tario. The instructions specified that the survey was to
be completed by the most senior clinical staff member.
CR programs were identified and contact information
secured in collaboration with the Cardiac Rehabilitation
Network of Ontario and Canadian Association of Car-
diac Rehabilitation.
For the third study, an anonymous online survey was
sent to all 765 cardiac specialist members of the CCS
treating adult patients indicated for CR (i.e., cardiologists,
cardiovascular surgeons and internists). The survey was
developed in conjunction with the CCS, and was sent out
by this organization to its membership in the spring of
2010. The survey was translated into French, and partici-
pants completed the survey in the language of their
choice. A personalized approach with repeated contacts
was used to optimize response rate for all 3 surveys.
The Canadian Cardiac Rehabilitation Registry is a na-
tional data collection system to assess the characteristics,
treatments and outcomes of patients participating in CR.
It is a retrospective source of consecutive participants
from participating centers, with the first patients in the
registry referred to CR in October 2006. Currently, there
are 10 programs contributing data to the Canadian Car-
diac Rehabilitation Registry, with a total of 2305 cases
(n = 1568 [68.1%] males; mean age: 61.6 ± 10.6). There
are an estimated 120 CR programs across the country,
suggesting that the registry represents slightly < 10% of
the overall CR population. Participating programs docu-
ment all CR outpatients using standardized data defini-
tions. The registry has undergone ethical and privacy
review.
Measures
The questionnaires were developed by the authors based
on available literature [12,14]. Clinical input from physi-
cians and other health care professionals with expertise
in CR were incorporated during survey development.
Pilot testing was undertaken with several members of
the target clinical audience, which informed minor re-
wording of some survey questions. All wait time items
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choice response options, Likert-type scales and some
items called for open-ended responses.
Each survey included sociodemographic and health
service/clinical items (as applicable; e.g., program char-
acteristics, province) assessed through forced-choice re-
sponse options. In the patient survey, respondents were
asked approximately how many weeks passed between
being discharged from hospital and starting the CR pro-
gram, and between being referred to CR and starting the
program. They were also asked whether they considered
the wait time to be “acceptable” or “unacceptable”, and
to respond why in an open-ended fashion. They were
asked to check (✓) as appropriate from a list of potential
reasons for delay in starting CR where applicable, if none
were applicable, or if another reason was applicable (and
to specify accordingly). Finally, participants were asked
to report ideally how many weeks they would like to
wait between being hospitalized for a cardiac event or
procedure and starting CR.
In the specialist survey, respondents were asked what
percentage of their eligible and their referred patients
start CR within 30 days from referral. Specialists were
provided a table with the CR indications, and the prefer-
able and acceptable wait times according to Canadian
consensus guidelines [12]. They were then asked to esti-
mate the percentage of their patients meeting the prefer-
able and acceptable benchmark. CR programs were
asked to report the average wait time between patient
referral and intake, and between intake and start of the
exercise program in days. Similar to the cardiac special-
ist survey, programs were provided a table with the CR
indications, and the preferable and acceptable wait
times. They were then asked to estimate the percentage
of patients meeting the preferable and acceptable bench-
mark at their respective sites, as well as their perceptions
of the appropriate number of days waiting for optimal
patient outcomes, and their perception of the feasible
number of days waiting based on their program capacity.
Finally, programs were provided with a list of patient,
physician, program and health system-level factors that
may contribute to wait times. Respondents were asked
to what degree they perceived each factor contributed to
wait times on a scale from 1 (“does not affect CR wait
time delays”) to 5 (“major factor affecting wait time
delays”). Finally, the Canadian Cardiac Rehabilitation
Registry collects data from participating CR programs
regarding the date of referral, date of referral receipt,
date of initial visit and date of program start. Wait times
in days were computed between these intervals.
Statistical analyses
All data analyses were performed using IBM SPSS version
17.0 (New York, USA) [16]. A descriptive examination ofthe characteristics of the patients, specialists and CR pro-
grams was performed. To test the first objective, a descrip-
tive examination of perceived and ideal patient wait times
was performed. Bivariate analyses to compare wait time
perceptions by patient indication were performed using
t-tests. To describe cardiac specialist and CR program per-
ceptions of the proportion of patients receiving CR within
CCS-recommended wait times [12], as well as whether
the recommendations are appropriate and feasible, a de-
scriptive examination was performed. Non-parametric
tests were then used to compare specialist and CR pro-
gram perceptions of benchmarks and wait times. Descrip-
tive statistics were used to describe program-reported CR
wait times, program awareness of wait time benchmarks,
and factors perceived to affect wait times.
Results
Characteristics of respondents
Self-reported characteristics of cardiac patients, cardiac
specialists, and CR programs are shown in Table 1,
Tables 2 and 3, respectively. Overall, 71 of 765 cardiac
specialists completed the online survey (9.3% response
rate). With regard to the CR programs, responses were
received for 42 of 44 Ontario programs (95.4% response
rate), and for 50 of 105 CR programs outside of Ontario
(47.6% response rate).
Cardiac patient perceptions of CR waits
The mean patient-reported wait time was 65.6 ± 88.4 days
(median, 42 days) from being discharged from hospital
to starting CR, and 40.1 ± 73.9 days (median, 28 days)
from referral to starting CR. Patients reported that they
waited from 7 days to 9.3 months from hospitalization
to commencement of CR, with 54 (33.1%) commencing
CR within the 30-day and 115 (64.6%) commencing
within the 60-day CCS benchmark. One hundred nine-
teen (91.5%) patients considered their wait time accept-
able. Patients reported that their ideal wait time between
cardiac event/procedure and commencement of CR was
33.1 ± 22.3 days (median, 28 days). Ninety-two (56.7%)
patients reported waiting longer from discharge to CR
start than their ideal wait time. As shown by Student’s
t-tests, patients who reported having a percutaneous cor-
onary intervention desired significantly shorter CR waits
than patients who did not have this procedure, while
patients with a history of bypass surgery or arrhythmia/
pacemaker desired longer waits than patients who did
not have this history (Table 1).
Patients were asked to give reasons for delays in acces-
sing CR. Twenty-one (16.9%) patients reported that they
had to wait until they were well enough to participate in
the program, 16 (12.9%) reported that they were waiting
for their doctor to send the paperwork, 15 (12.1%)
reported that there was a waiting list at the rehabilitation
Table 1 Characteristics of CR enrollees, and relation of clinical characteristics to ideal wait time (N=163)
Characteristic n (%) Perceived wait time from
hospital discharge to CR,
in days (Mean± SD)
Ideal wait time,
in days (Mean± SD)
Association between
indication and
ideal wait time†, t
Sociodemographic Characteristics
Males (%) 128 (78.5) - - -
Age (mean yrs ± SD) 62.8 ± 11.3 - - -
Caucasian (%) 122 (80.3) - - -
Retired (%) 66 (43.4) - - -
Income (%≥ $50,000 CDN) 53 (42.1) - - -
Indication / Previous Cardiovascular History*
Percutaneous coronary intervention (%) 50 (33.3) 58.8 ± 55.8 26.4 ± 17.8 −2.66}}
Myocardial infarction (%) 49 (32.7) 60.7 ± 46.6 36.7 ± 27.7 1.1
Angina (%) 34 (22.7) 79.1 ± 116.4 27.5 ± 20.8 −1.83
Coronary artery bypass graft (%) 37 (24.7) 61.8 ± 31.9 46.9 ± 23.4 4.05}}}
Arrhythmia /pacemaker (%) 16 (10.7) 85.9 ± 67.4 50.9 ± 21.7 2.57}
Stroke (%) 14 (9.3) 70.6 ± 57.4 22.3 ± 20.5 −1.71
Heart failure (%) 8 (5.3) 210.6 ± 240.7 38.0 ± 28.0 0.49
*Note: participants were asked to self-report all previous events and procedures from those listed.
§p<0.05;§§p<0.01;§§§p<0.001.
†Compared ideal wait time to presence or absence of each listed indication using t-tests.
CR = cardiac rehabilitation.
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sonal time conflict, which delayed their start in the pro-











British Columbia 8 (11.3%)
Saskatchewan 4 (5.6%)
New Brunswick 2 (2.8%)
Newfoundland 2 (2.8%)
Manitoba 1 (1.4%)
Nova Scotia 1 (1.4%)




Language of Survey Completed
English 62 (87.3%)
French 9 (12.7%)12 (9.7%) reported other reasons, such as awaiting fur-
ther diagnostic tests or cardiac procedures.Cardiac specialists’ perceptions of CR wait times
When specialists were asked whether they were aware of
the CCS Access to Care CR wait time benchmarks, 29
(40.8%) responded affirmatively. Cardiac specialists per-
ceived that 32.9% of their indicated patients started CR
within 30 days from referral, and that 41.5% of their re-
ferred patients started CR within 30 days from referral.
Table 4 displays specialist perceptions of the percentage
of patients meeting the preferable and acceptable wait
times, and perceptions of what are appropriate wait
times by type of CR indication.Table 3 Characteristics of CR programs (N=92)
Element
Education, n (%) 89 (96.7%)
Core element of exercise, n (%) 88 (95.7%)
Risk factor identification, n (%) 85 (92.4%)
Exercise testing, n (%) 85 (92.4%)
Interprofessional team, n (%) 78 (84.8%)
Medical assessment, n (%) 70 (76.1%)
Patient Capacity*, Mean± SD (Median) 624.6 ± 1607.0 (275)
Receive Government Funding, n (%) 56 (70.0%)
* Patient capacity refers to the number of patients the program can serve
each year, in terms of staff and space.
Table 4 Cardiac specialist and CR program perceptions of CR wait times in calendar days
Indication CCS wait time benchmarks Specialist responses, N= 71 mean± SD (median) CR program responses, N= 92 mean± SD (median)

























CABG 21-30 30-60 25.4 ± 25.0 (20) 49.5 ± 31.5 (50) 40.0 ± 20.7 (30) 34.1 ± 36.5 (20) 63.3 ± 32.8 (73)** 30.0 ± 17.2 (30)* 43.4 ± 30.9 (42)†††
Valvular disease 21-30 30-60 25.6 ± 25.6 (20) 46.0 ± 31.6 (50) 40.2 ± 20.2 (30) 34.2 ± 36.5 (20) 64.2 ± 33.6 (75)** 29.2 ± 15.9 (30)** 42.0 ± 31.6 (41)†††
Percutaneous coronary
intervention
2-7 7-60 17.7 ± 24.7 (10) 54.4 ±33.4 (60) 20.5 ± 12.6 (14) 21.8 ± 31.3 (7) 68.1 ± 32.6 (75)* 14.7 ± 12.5 (10)* 31.7 ± 35.7 (20)†††
Myocardial infarction 7-30 30-60 34.1 ± 27.7 (30) 54.0 ± 31.8 (50) 28.2 ± 18.0 (30) 37.5 ± 35.3 (30) 58.5 ± 33.1 (60) 20.6 ± 16.1 (17)* 36.0 ± 35.3 (21)†††
Heart failure 7-30 30-60 25.3 ±24.4 (20) 42.0 ± 33.2 (30) 29.0 ± 17.9 (30) 34.8 ± 35.8 (21) 58.9 ± 36.0 (60)* 17.5 ± 13.3 (14)*** 30.5 ± 28.5 (22)††
Stable angina 7-30 30-60 30.1 ± 27.9 (20) 43.5 ± 32.9 (40) 34.2 ± 20.7 (30) 39.9 ± 35.2 (30) 58.1 ± 34.9 (60)* 18.9 ± 17.9 (14)*** 33.6 ± 36.9 (21)††
Heart transplantation 4-10 10-60 36.1 ± 40.6 (25) 41.1 ± 40.4 (25) 43.2 ± 125.5 (21) 18.5 ± 28.6 (0) 52.9 ± 39.9 (56) 26.2 ± 19.0 (21) 34.3 ± 22.0 (30)††
Arrhythmias 1-30 30-60 41.9 ± 121.7 (20) 53.8 ± 118.5 (21) 47.4 ± 104.3 (30) 34.8 ± 35.0 (22) 57.5 ± 35.0 (60)** 18.0 ± 15.5 (14)*** 36.0 ± 37.6 (21)†††
*Note: CABG= coronary artery bypass grafting; CCS = Canadian Cardiovascular Society; CR = cardiac rehabilitation.
*p < 0.05; **p < 0.01; ***p < 0.001, independent samples t-tests comparing specialists with CR program perceptions of the percentage of patients meeting preferable and acceptable benchmarks, and of the appropriate
number of days’ wait.





















Table 5 National CR program perceptions of factors
affecting CR wait times (n =92)
Factor Mean Standard
deviation
Patient travel constraints, scheduling
unavailability
3.7 1.2
Capacity issues: staffing 3.6 1.2
Physician initiates patient referral at
outpatient visit after hospital discharge
3.6 1.2
Lack of funding 3.6 1.4
Scheduling limitations 3.5 1.3
Lack of consistent implementation of
discharge order sets including
CR referral
3.5 1.4
Capacity issues: operating hours 3.2 1.4
Lack of availability of alternative CR
program models
3.2 1.2
Capacity issues: facility space 3.2 1.5
Geographic siting of programs 3.1 1.4
Waiting for referral information 3.0 1.3
Waiting for exercise test results 3.0 1.5
Capacity issues: lack of equipment 2.6 1.3
Patient confidentiality legislation 1.8 1.0
Note: scores range from 1 (“does not affect CR wait time delays”) to 5 (“major
factor affecting wait time delays”).
CR = cardiac rehabilitation.
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Nationally, the median wait time reported in the registry
from referral to CR program start was 64 days (mean ±
SD, 80.0 ± 62.8 days). There was no significant differ-
ence in wait time by indication (bypass or valve surgery,
96.5 ± 51.8 days; percutaneous coronary intervention,
93.2 ± 69.2 days; myocardial infarction/heart failure/
stable and unstable angina, 97.0 ± 66.7 days; there were
insufficient arrhythmia and transplant data to report reli-
ably). Median wait times by program varied from a mini-
mum of 36 to a maximum of 127 days. The median wait
time from referral receipt to intake was 22 days (mean,
30.82 ± 38.51 days), and from intake to initiation of the
exercise program was 28 days (mean, 40.98 ± 51.59 days).
CR programs perceived that a significantly greater per-
centage of bypass surgery, valve disease, percutaneous
coronary intervention, stable angina, and heart failure
patients met the acceptable wait time benchmarks com-
pared with cardiac specialists’ perceptions (Table 4). In
addition, for all indications, except for heart transplant-
ation, CR programs perceived significantly shorter ap-
propriate wait times than cardiac specialists. Finally, CR
program perceptions of the feasible number of days’ wait
was significantly greater than what was appropriate for
all indications.
When CR programs were asked whether they were
aware of the CCS Access to Care CR wait time bench-
marks, 49 (53.8%) responded affirmatively. Forty-seven(51.1%) programs reported that they had wait time
benchmarks. When programs were asked to describe
them, 20 (43.5%) reported that their program has a set
wait limit, 11 (23.9%) reported that their benchmarks
are in accordance with the Canadian Association of Car-
diac Rehabilitation (CACR) guidelines [17], 8 (17.4%)
reported their program’s benchmark range, 3 (6.5%)
reported that their benchmarks vary by indication, 2
(4.3%) reported that there is no wait time in their pro-
gram, and 2 (4.3%) reported that they have wait time
goals to the first patient phone contact only (n = 1 did
not specify). Overall, programs with wait time bench-
marks estimated that 75.5 ± 26.0% of the time they meet
them (median, 80%).
In the CR survey, program respondents rated the de-
gree to which factors from the patient to health system-
level affect CR wait times (Table 5). Factors listed by CR
programs were patient illness, preference for specific ex-
ercise times, individual readiness to participate, slow
General Practitioner referrals and limited availability of
stress testing.
Discussion
The present study is the first published national evalu-
ation of the timeliness of access to CR, based on percep-
tions of patients, providers, and CR programs compared
with national guidelines. Our study provides insight
regarding the views and perceptions of different stake-
holders on a topic that is, both in daily practice and in
national policies, often determined by non-empirical as-
sessment among a small number of individuals. There is
no objective standard for acceptable wait times, other
than participation rates [3,4,18,19] and some emerging
evidence of a relationship between wait time and peak
oxygen consumption achieved [20,21] at this time, but
our analysis of the subjective views of these stakeholders
has provided important information regarding the ap-
propriateness of the consensus recommendations.
Patient perceptions of CR waits
The current study found that, overall, the median wait
for patients to access CR was 42 days, which exceeds
the 30-day CCS benchmark [12] by 40%. Registry data
suggests that almost half of this time was spent waiting
for the referral documentation to be generated and
transmitted by a healthcare provider, and just over half
was spent waiting for their intake appointment to be
scheduled and assessments completed to commence the
individually-tailored exercise program. This finding sug-
gests that, to reduce wait times, strategies need to be
targeted to both the pre-referral process, as well as the
post-referral process.
However, over 90% of patients considered their wait ac-
ceptable. Their ideal wait was 28 days, which is highly
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[12]. The most common reasons reported for delays in
access were the patient’s health status, followed by phys-
ician delays in transmitting clinical information to CR. In
contrast, CR programs perceived that the most common
reasons for delays in access were patient unavailability
for personal reasons, capacity and funding limitations, as
well as delayed physician referral.
Healthcare providers and CR waits
Overall, cardiac specialists in Canada perceived that only
approximately 1/3 of their indicated patients were acces-
sing CR within the 30-day recommended wait time over-
all. This varied by CR indication, with physicians
perceiving that a median of 10-30% of patients meet the
“preferable” benchmarks, and 21-60% of patients meet
the “acceptable” benchmarks. In particular, they per-
ceived that only 10% of percutaneous coronary interven-
tion patients meet the preferable wait times, and 1/5-1/3
of arrhythmia, transplant and heart failure patients meet
the acceptable wait times.
CR programs and specialists generally perceived that
the same degree of patients were meeting the preferable
CR wait times, but CR programs tended to perceive that
more patients were meeting the acceptable benchmarks
than the specialists. Specialist perceptions of the appro-
priate number of days’ of wait by CR indication were all
at the high end or exceeded the CCS preferable wait
time benchmarks, and were at the low end of the accept-
able benchmarks. With the exception of percutaneous
coronary intervention patients, it was notable that the
specialists’ views on appropriate waiting times largely
matched the CR programs’ views of feasible waiting
times. This suggests that what is considered appropriate
according to specialists could be feasible within current
funding policies. CR program perceptions of the feasible
number of days’ wait were significantly higher than what
was considered appropriate. These findings allude to the
limited capacity in the health system to deliver the high-
est quality care.
Overall, a patient’s median wait time from referral re-
ceipt to the start of CR in Canada is 64 days. Consider-
ing that this does not reflect the time waiting from the
referral event, this exceeds the 30-day recommendation.
However, the overall consensus based on patient, spe-
cialist and CR program perceptions, as well as registry
data, suggests that patients generally access CR around
the acceptable wait time range of 60 days in Canada.
Strategies to reduce CR wait times
Our overall findings suggest that some patients perceive
that they are experiencing prolonged CR waits, and in
particular, wait times for percutaneous coronary inter-
vention patients need to be addressed. There are 2specific approaches that are successful in mitigating CR
wait times. First, interprofessional education classes can
be offered to patients shortly after hospital discharge.
Provision of these sessions may encourage earlier adop-
tion of heart health-promoting behavior, provide reassur-
ance to patients and family members, enable verification
of discharge instructions, ensure identification of any
clinical issues, which may have arisen, such as infection,
and mitigate some causes of wait time delays [22]. Sec-
ond, other programs have liaised with inpatient cardiac
wards within their institutions to facilitate initiation of
CR referral before patient discharge, rather than at a
post-discharge visit weeks or months later. Such referral
strategies are shown to cut CR wait times in half [23]. In-
deed, a recent CCS-CACR policy position recommends
that all indicated patients be referred to CR systematic-
ally prior to discharge via a standard order [24].
In response to perceived access delays for patients,
some CR programs have instituted innovative practices.
Indeed, quality management strategies have been suc-
cessfully implemented to significantly reduce wait times
to access chronic disease management programming
[25], such as process mapping, and performance data
collection and evaluation [26]. For example, in response
to delays in booking intake exercise stress tests required
to initiate an exercise program, some CR programs no
longer require a stress test prior to CR initiation in low-
risk patients or use a six-minute walk test. Clearly, all
quality management strategies need to take into consid-
eration, not only the patient experience, but also safety
and patient outcome.
Limitations
Caution is warranted when interpreting results from the
current study, mostly because of generalizability and
measurement issues. There was a considerably low re-
sponse to the cardiac specialist survey. Therefore, it can-
not be determined whether our results are representative
of cardiac specialists across the country. Respondents
were primarily Ontario cardiologists in urban settings. In
a review of physician response to surveys, demographic
characteristics of late respondents (considered to be a
proxy for non-respondents) were similar to the character-
istics of respondents to the first mailing [27]. Moreover,
physicians as a group are more homogeneous with regard
to knowledge, training, attitudes, and behaviour than the
general population, suggesting that nonresponse bias may
not be as crucial in physician surveys as in surveys of the
general population [27]. In addition, the response rate of
patients is unknown, although CR participant response
rates are usually high.
Second, respondents were mainly providing percep-
tions of wait times, and therefore, there might have been
some error associated with the wait time estimates. Wait
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compensate for this limitation. However, it remains un-
known whether different stakeholders may be over or
under-estimating waits. Third, the multiple comparisons
made between cardiac specialist and CR program percep-
tions may have resulted in inflated error rates. A more con-
servative approach was not adopted given the lack of
information known in this domain; therefore, further study
is warranted. Finally, the cross-sectional design precludes
causal conclusions.
Conclusions
In conclusion, wait times for access to CR may be pro-
longed compared with consensus recommendations [12],
but they are generally acceptable to most patients. The dif-
fering views of stakeholder groups regarding acceptability
and appropriateness of wait times and the cause of delays
highlight the need for further research. Clearly, the timing
is right to establish an evidence base for wait time bench-
marks in Canada, as well as for other countries.
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